Cel Sci Corp Stock Market Value
| CVM Stock | USD 4.98 0.26 4.96% |
| Symbol | CEL |
Will Biotechnology sector continue expanding? Could CEL diversify its offerings? Factors like these will boost the valuation of CEL SCI. Projected growth potential of CEL fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CEL SCI data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (5.99) | Revenue Per Share | Quarterly Revenue Growth (0.63) | Return On Assets | Return On Equity |
Understanding CEL SCI Corp requires distinguishing between market price and book value, where the latter reflects CEL's accounting equity. The concept of intrinsic value - what CEL SCI's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push CEL SCI's price substantially above or below its fundamental value.
It's important to distinguish between CEL SCI's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CEL SCI should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, CEL SCI's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
CEL SCI 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CEL SCI's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CEL SCI.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in CEL SCI on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding CEL SCI Corp or generate 0.0% return on investment in CEL SCI over 90 days. CEL SCI is related to or competes with INmune Bio, Barinthus Biotherapeutics, Aligos Therapeutics, Kezar Life, OnKure Therapeutics, Tempest Therapeutics, and X4 Pharmaceuticals. CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious ... More
CEL SCI Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CEL SCI's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CEL SCI Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 30.91 | |||
| Value At Risk | (9.65) | |||
| Potential Upside | 10.19 |
CEL SCI Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CEL SCI's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CEL SCI's standard deviation. In reality, there are many statistical measures that can use CEL SCI historical prices to predict the future CEL SCI's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (0.85) | |||
| Treynor Ratio | (1.13) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CEL SCI's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CEL SCI February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (1.12) | |||
| Mean Deviation | 4.7 | |||
| Coefficient Of Variation | (1,757) | |||
| Standard Deviation | 6.37 | |||
| Variance | 40.63 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (0.85) | |||
| Treynor Ratio | (1.13) | |||
| Maximum Drawdown | 30.91 | |||
| Value At Risk | (9.65) | |||
| Potential Upside | 10.19 | |||
| Skewness | 0.6479 | |||
| Kurtosis | 1.78 |
CEL SCI Corp Backtested Returns
CEL SCI Corp secures Sharpe Ratio (or Efficiency) of -0.0487, which signifies that the company had a -0.0487 % return per unit of return volatility over the last 3 months. CEL SCI Corp exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CEL SCI's Risk Adjusted Performance of (0.03), mean deviation of 4.7, and Coefficient Of Variation of (1,757) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.33, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CEL SCI's returns are expected to increase less than the market. However, during the bear market, the loss of holding CEL SCI is expected to be smaller as well. At this point, CEL SCI Corp has a negative expected return of -0.3%. Please make sure to confirm CEL SCI's value at risk, as well as the relationship between the daily balance of power and price action indicator , to decide if CEL SCI Corp performance from the past will be repeated in the future.
Auto-correlation | -0.19 |
Insignificant reverse predictability
CEL SCI Corp has insignificant reverse predictability. Overlapping area represents the amount of predictability between CEL SCI time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CEL SCI Corp price movement. The serial correlation of -0.19 indicates that over 19.0% of current CEL SCI price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.19 | |
| Spearman Rank Test | -0.32 | |
| Residual Average | 0.0 | |
| Price Variance | 0.3 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out CEL SCI Correlation, CEL SCI Volatility and CEL SCI Performance module to complement your research on CEL SCI. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
CEL SCI technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.